These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 2619560)
1. In vivo and in vitro regional differential sensitivity of neuropathy target esterase to di-n-butyl-2,2-dichlorovinyl phosphate. Moretto A; Lotti M; Spencer PS Arch Toxicol; 1989; 63(6):469-73. PubMed ID: 2619560 [TBL] [Abstract][Full Text] [Related]
3. Age sensitivity to organophosphate-induced delayed polyneuropathy. Biochemical and toxicological studies in developing chicks. Moretto A; Capodicasa E; Peraica M; Lotti M Biochem Pharmacol; 1991 May; 41(10):1497-504. PubMed ID: 2018554 [TBL] [Abstract][Full Text] [Related]
4. The phosphorothioic acid O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase. Moretto A; Bertolazzi M; Lotti M Toxicol Appl Pharmacol; 1994 Nov; 129(1):133-7. PubMed ID: 7974486 [TBL] [Abstract][Full Text] [Related]
5. Organophosphate polyneuropathy in chicks. Peraica M; Capodicasa E; Moretto A; Lotti M Biochem Pharmacol; 1993 Jan; 45(1):131-5. PubMed ID: 8381002 [TBL] [Abstract][Full Text] [Related]
6. Clinical expression of organophosphate-induced delayed polyneuropathy in rats. Moretto A; Capodicasa E; Lotti M Toxicol Lett; 1992 Oct; 63(1):97-102. PubMed ID: 1412529 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the relative inhibition of acetylcholinesterase and neuropathy target esterase in rats and hens given cholinesterase inhibitors. Ehrich M; Jortner BS; Padilla S Fundam Appl Toxicol; 1995 Jan; 24(1):94-101. PubMed ID: 7713347 [TBL] [Abstract][Full Text] [Related]
8. Repeated low doses of O-(2-chloro-2,3,3 trifluorocyclobutyl) O-ethyl S-propyl phosphorothioate (KBR-2822) do not cause neuropathy in hens. Jokanovic M; Moretto A; Lotti M Arch Toxicol; 1998; 72(2):93-6. PubMed ID: 9456080 [TBL] [Abstract][Full Text] [Related]
10. Progressive deficit of retrograde axonal transport is associated with the pathogenesis of di-n-butyl dichlorvos axonopathy. Moretto A; Lotti M; Sabri MI; Spencer PS J Neurochem; 1987 Nov; 49(5):1515-22. PubMed ID: 2444671 [TBL] [Abstract][Full Text] [Related]
11. Phenylmethanesulfonyl fluoride elicits and intensifies the clinical expression of neuropathic insults. Moretto A; Bertolazzi M; Capodicasa E; Peraica M; Richardson RJ; Scapellato ML; Lotti M Arch Toxicol; 1992; 66(1):67-72. PubMed ID: 1316117 [TBL] [Abstract][Full Text] [Related]
12. Relationship of neuropathy target esterase inhibition to neuropathology and ataxia in hens given organophosphorus esters. Ehrich M; Jortner BS; Padilla S Chem Biol Interact; 1993 Jun; 87(1-3):431-7. PubMed ID: 8343999 [TBL] [Abstract][Full Text] [Related]
13. Biochemical and clinical tests of the delayed neuropathic potential of some O-alkyl O-dichlorophenyl phosphoramidate analogues of methamidophos (O,S-dimethyl phosphorothioamidate). Johnson MK; Vilanova E; Read DJ Toxicology; 1989 Jan; 54(1):89-100. PubMed ID: 2536970 [TBL] [Abstract][Full Text] [Related]
14. Phenyl di-n-pentylphosphinate: a convenient reactivatible inhibitor for studies on neuropathy target esterase (NTE) and protection against organophosphate-induced delayed polyneuropathy. Johnson MK; Bird I; Meredith C Toxicol Lett; 1988 Feb; 40(2):133-40. PubMed ID: 2829392 [TBL] [Abstract][Full Text] [Related]
15. Anomalous biochemical responses in tests of the delayed neuropathic potential of methamidophos (O,S-dimethyl phosphorothioamidate), its resolved isomers and of some higher O-alkyl homologues. Johnson MK; Vilanova E; Read DJ Arch Toxicol; 1991; 65(8):618-24. PubMed ID: 1660708 [TBL] [Abstract][Full Text] [Related]
16. The relationship between isofenphos cholinergic toxicity and the development of polyneuropathy in hens and humans. Moretto A; Lotti M Arch Toxicol; 2002 Jun; 76(5-6):367-75. PubMed ID: 12107655 [TBL] [Abstract][Full Text] [Related]
17. Discrimination of carboxylesterases of chicken neural tissue by inhibition with a neuropathic, non-neuropathic organophosphorus compounds and neuropathy promoter. Céspedes MV; Escudero MA; Barril J; Sogorb MA; Vicedo JL; Vilanova E Chem Biol Interact; 1997 Oct; 106(3):191-200. PubMed ID: 9413546 [TBL] [Abstract][Full Text] [Related]
18. The influence of chirality on the delayed neuropathic potential of some organophosphorus esters: neuropathic and prophylactic effects of stereoisomeric esters of ethyl phenylphosphonic acid (EPN oxon and EPN) correlate with quantities of aged and unaged neuropathy target esterase in vivo. Johnson MK; Read DJ Toxicol Appl Pharmacol; 1987 Aug; 90(1):103-15. PubMed ID: 3629585 [TBL] [Abstract][Full Text] [Related]
19. Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride. Lotti M; Caroldi S; Capodicasa E; Moretto A Toxicol Appl Pharmacol; 1991 Apr; 108(2):234-41. PubMed ID: 2017753 [TBL] [Abstract][Full Text] [Related]
20. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy. Milatovic D; Moretto A; Osman KA; Lotti M Chem Res Toxicol; 1997 Sep; 10(9):1045-8. PubMed ID: 9305588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]